Why does conventional chemical dosing keep failing?
Most waterborne pathogens do not float freely where a dose of chlorine can reach them. They live inside biofilm, a protective layer on the inside of pipes and tanks, where they are roughly a thousand times more resistant to conventional disinfectants than free-floating cells. A chlorine-based dose can knock down what is in the water column and leave the reservoir in the biofilm untouched, so the contamination returns.
The pattern is familiar on real sites. At one major UK airport, a recurring pathogen problem was dosed again and again, in one stretch as many as twenty-five times at around GBP 1,950 a treatment, and it kept coming back. The dosing was treating the symptom in the water, not the biofilm that kept reseeding it.
What does chemical dependency actually cost?
The cost is not only the chemical. It is the repeat treatments, the handling and storage of hazardous product, the labour, and the standing compliance risk every time the problem recurs. Heavier dosing also carries an environmental price, and the water sector is under tightening scrutiny over the chemicals it uses and discharges.
And it rarely buys certainty. If the biofilm is intact, the next failed test is a question of when, not if, which is exactly the exposure a water-safety duty-holder cannot carry.
What does designing it out look like?
Designing out chemical dependency means going after the biofilm itself, at source, rather than chasing the water with ever larger doses. Approaches that target biofilm directly are independently shown to remove 99.99% of it using a recognised standard method (ASTM E2799), which is the failure mode conventional dosing leaves behind.
Done that way, the system needs less chemistry, not more, to stay safe. At the airport above, the bioload fell from 600 to 0 cfu/g in four days, confirmed by a UKAS-accredited laboratory, and held on a routine maintenance dose. At a private estate, 62.5 litres treated 1.6 million litres of water, clearing the biofilm and returning zero Legionella, E. coli and coliforms, verified by a water-authority laboratory. The headline is the same in both: less chemical volume, a better result, and independent evidence for it.
Does less chemistry mean more risk?
No, provided the goal is reframed from dosing to control. The duty under the relevant water-safety codes is to keep pathogen risk under reliable, compliant control, and to be able to prove it. Targeting the biofilm and verifying the result independently meets that bar with a lower residual chemical load, which is better for swimmers, staff, equipment and the environment.
It also matters more over time. As antimicrobial resistance rises, the biofilm that shelters resistant organisms becomes the part of the system you least want to leave untreated. Designing out chemical dependency is, in the end, designing in control.